PYY3-36 - Aditech Pharma
Alternative Names: PYY3-36-Aditech Pharma; PYY336Latest Information Update: 08 Nov 2024
Price :
$50 *
At a glance
- Originator AdiTech Pharma
- Class Obesity therapies; Peptide hormones
- Mechanism of Action Lipolysis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Obesity